Scottsdale 10/23/2013 3:00:00 AM
News / Stocks

Nutranomics (NNRX) Releases Results from Clinical Studies of Glucozyme™ for Patients with Type 2 Diabetes

QualityStocks would like to highlight NutraNomics (OTCQB: NNRX), developer of nutritional food products, for their own product line as well as other companies. As part of that, the company considers it their mission to increase human health and longevity through education and self-awareness.  They teach that all must take responsibility for their own health through moderate diets, exercise, and proper supplementation.  

In the company’s news,

Nutranomics reports data from several human patient clinical studies regarding Glucozyme™, a proprietary nutritional supplement designed to assist in the reduction of blood glucose levels in patients with Type 2 diabetes.

NNRX conducted one study “in-house” while another was conducted in a Hispanic clinic in Salt Lake City, Utah, and one conducted by a clinic in Tokyo, Japan.

The three separate clinical studies measured both the fasting glucose levels and the HbA1-c levels of Type 2 diabetics for 30, 60, and 90 days, demonstrating Glucozyme’s ability to reduce blood sugar levels and HbA1-c levels in patients by 22-28 percent within the 90-day period.

“The results of the three separate studies were overwhelmingly positive and show that Glucozyme is effective at reducing the blood sugar levels in patients across a diverse ethnic population,” Dr. Tracy K. Gibbs, CEO of NNRX stated via news release. “Based on these results, we are now preparing to launch Glucozyme globally.”

NNRX said that Glucozyme in upcoming weeks will be available for purchase on the company’s website, and that it is educating its sales force and distributors on the product.

About QualityStocks

QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.

To sign up for The QualityStocks Daily Newsletter, please visit www.QualityStocks.com  

To connect with QualityStocks via Facebook, please visit http://Facebook.com/QualityStocksPage

To connect with QualityStocks via Twitter, please visit http://Twitter.com/QualityStocks

Please read FULL disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com   

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.